HPR+ patients in both T2DM and hypercholesterolemia (HC) have a lower activity of plasma extracellular SOD, and platelet response to collagen/epinephrine platelet function analyzer-100 (CEPI PFA-100) indicates that only SOD substantially predicted platelet reactivity. The gene discussed is SOD1; the disease is familial hypercholesterolemia.